FPS
CELG

Fieldpoint Private Securities’s Celgene Corp CELG Stock Holding History

Fieldpoint Private Securities’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20
Closed -$2K – 746
2019
Q3 		$2K Sell
20
-875
-98% -$83.1K ﹤0.01% 687
2019
Q2 		$83K Sell
895
-1,403
-61% -$133K 0.03% 359
2019
Q1 		$217K Buy
2,298
+1,698
+283% +$149K 0.09% 186
2018
Q4 		$38K Buy
+600
New +$44.3K 0.02% 300
2018
Q2 		– Sell
-400
Closed -$36K – 436
2018
Q1 		$36K Sell
400
-1,400
-78% -$134K 0.02% 313
2017
Q4 		$188K Buy
1,800
+479
+36% +$54K 0.1% 168
2017
Q3 		$193K Buy
1,321
+1,221
+1,221% +$166K 0.08% 196
2017
Q2 		$13K Hold
100
– – 0.01% 144
2017
Q1 		$12K Buy
+100
New +$12K 0.01% 303

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Fieldpoint Private Securities's CELG Position: Q4 2019 in Review

Fieldpoint Private Securities sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 20 shares — an estimated $2K sold.

Fieldpoint Private Securities first reported a position in CELG in Q1 2017 and held it in 9 quarters. The position peaked at $217K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Fieldpoint Private Securities reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Fieldpoint Private Securities sold 20 Celgene Corp shares in Q4 2019, an estimated $2K.
  • Fieldpoint Private Securities first reported a position in Celgene Corp in Q1 2017 and held it in 9 quarters.
  • Fieldpoint Private Securities's Celgene Corp position peaked at $217K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Fieldpoint Private Securities's 13F filing for Q4 2019, filed 10 Feb 2020.